antibody

Anti-ETBR Antibody (DEDN6526A Naked Antibody) is a highly specific monoclonal antibody targeting the endothelin B receptor (ETBR) and serves as the antibody for the ADC molecule DEDN6526A. DEDN6526A (RG-7636) is a humanized ETBR-targeting antibody-drug conjugate developed for melanoma research.

Anti-STEAP2 Antibody (AZD0516 antibody) is a selective inhibitor of the prostate-specific six transmembrane epithelial antigen 2 (STEAP2). It inhibits the proliferation, migration, and invasion of prostate cancer cells by blocking the STEAP2-mediated ERK/MAPK signaling pathway. Anti-STEAP2 Antibody shows potential for prostate cancer research.

IgG has four forms, provides the majority of antibody-based immunity against invading pathogens. The only antibody capable of crossing the placenta to give passive immunity to the fetus. Eliminates pathogens in the early stages of B cell-mediated (humoral

RG7841 is a humanized antibody targeting Ly6E, which can be used to study lung cancer.

Anti-CD46 Antibody (FOR46 Naked Antibody) is a humanized antibody targeting CD46, used in prostate disease and myeloma research.

Anti-FLT3 Antibody (AGS62P) is an ADC antibody targeting FLT3 for research in acute myeloid leukemia.

The Anti-Mouse Nonclassical MHC Class I molecule Qa-1b Antibody (4C2.4A7.5H11) is a mouse-derived IgG1 antibody targeting the Qa-1b nonclassical MHC Class I molecule. The isotype control for this compound is Mouse IgG1 kappa, Isotype Control.

Anti-TM4SF1 Antibody is a human-derived antibody expressed in CHO cells, targeting TM4SF1. It consists of a human IgG1 heavy chain and a human κ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control reference, see HumanIgG1kappa, Isotype Control.

Anti-CLDN6 Antibody (DS-9606A antibody) is a human-derived antibody expressed in CHO cells, targeting CLDN6. It features an IgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.84 kDa. For isotype control, please refer to HumanIgG1kappa, Isotype Control.

Anti-GPR20 Antibody (DS-6157 antibody) is a CHO-expressed human-derived antibody targeting GPR20. It features a huIgG1 heavy chain and a huκ light chain, with an estimated molecular weight (MW) of 150 kDa. For its isotype control, refer to Human IgG1 kappa, Isotype Control.

Anti-ALPP Antibody (SGN-ALPV antibody) is a human-derived monoclonal antibody (mAb) targeting ALPP. It is applicable for research on solid tumors.

Anti-TROP2 Antibody (RN927C antibody) is a human-derived monoclonal antibody (mAb) that targets TROP2. It exhibits in vitro inhibitory effects on various tumor cell lines. The Anti-TROP2 Antibody also demonstrates antitumor activity in mouse models including pancreatic PDX, ovarian PDX, lung LG0476 PDX, and triple-negative breast cancer (TNB) PDX.

Anti-Tenascin C Antibody (Neuradiab antibody) is a human-derived monoclonal antibody (mAb) that specifically targets Tenascin C. It is utilized in the research of glioblastoma. The suggested isotype control is Human IgG1 kappa, Isotype Control.

SGN-PDL1V Antibody is an antibody that targets PD-L1. It can be utilized in the synthesis of ADCs for the compound ADCSGN-PDL1V.

Anti-FOLH1/PSMA Antibody (J591) (MEDI3726 antibody; ADCT-401 antibody) is a humanized monoclonal antibody (mAb) that specifically targets PSMA. This antibody is utilized in prostate cancer research.

HS-20093 Antibody is an antibody-drug conjugate (ADC) targeting B7-H3, demonstrating antitumor activity. It is applicable for research involving small cell lung cancer, relapsed or refractory osteosarcoma, and advanced solid tumors.

Anti-CD44 Antibody (VB6-008 antibody) is an IgG1 monoclonal antibody targeting CD44, useful for tumor research.

Anti-CA6 Antibody (huDS6) is an antibody that specifically targets the sialic acid sugar epitope associated with mucin 1 (CA6). It is utilized in the synthesis of antibody-drug conjugates (ADCs).

The Anti-TDGF1 antibody (huB3F6) (BIIB015 antibody) is a human-derived antibody expressed in CHO cells, targeting TDGF1. It features a huIgG1 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 145 kDa. For isotype control, refer to HumanIgG1kappa, Isotype Control. This antibody is applicable in the synthesis of ADCs.

Anti-CD33 Antibody (IMGN-779 Naked Antibody) is a humanized antibody targeting CD33 with antileukemic activity, which can be used to study leukemia.

Anti-SLC44A4 Antibody (ASG-5ME Antibody) is an antibody that targets SLC44A4, used for synthesizing ADC ASG-5ME.

Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) is an IgG2a, κ antibody inhibitor derived from mice and specifically targets the rat κ immunoglobulin light chain.

Anti-Mouse/Human/Rat/Monkey/Hamster/Canine/Bovine TGF-β Antibody (1D11.16.8) is an IgG antibody inhibitor targeting TGF-β in multiple species including mouse, human, rabbit, monkey, hamster, dog, and cow. For information on the isotype control, refer to Mouse IgG1 kappa, Isotype Control.

Anti-Human/Mouse denatured collagen type-I Antibody (XL313) is an IgG1, κ inhibitor derived from mice, targeting denatured collagen type-I in both human and mouse.